Breaking News

FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions

Delivering 2023 traceability by leveraging blockchain and digital recalls across a supply network

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

TraceLink has been accepted for participation in the U.S. Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA). TraceLink’s pilot project focuses on two work streams—an interoperable blockchain network solution and digital recalls across a supply network—both intended to bring together participants of all sizes from across the pharmaceutical supply chain to enhance patient safety and address challenging business processes through network...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters